These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22997248)

  • 1. Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy.
    Li J; Kritzer MD; Michel JJ; Le A; Thakur H; Gayanilo M; Passariello CL; Negro A; Danial JB; Oskouei B; Sanders M; Hare JM; Hanauer A; Dodge-Kafka K; Kapiloff MS
    Circ Res; 2013 Jan; 112(1):128-39. PubMed ID: 22997248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signalosome-Regulated Serum Response Factor Phosphorylation Determining Myocyte Growth in Width Versus Length as a Therapeutic Target for Heart Failure.
    Li J; Tan Y; Passariello CL; Martinez EC; Kritzer MD; Li X; Li X; Li Y; Yu Q; Ohgi K; Thakur H; MacArthur JW; Ivey JR; Woo YJ; Emter CA; Dodge-Kafka K; Rosenfeld MG; Kapiloff MS
    Circulation; 2020 Dec; 142(22):2138-2154. PubMed ID: 32933333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RSK3: A regulator of pathological cardiac remodeling.
    Martinez EC; Passariello CL; Li J; Matheson CJ; Dodge-Kafka K; Reigan P; Kapiloff MS
    IUBMB Life; 2015 May; 67(5):331-7. PubMed ID: 25988524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p90 ribosomal S6 kinase 3 contributes to cardiac insufficiency in α-tropomyosin Glu180Gly transgenic mice.
    Passariello CL; Gayanilo M; Kritzer MD; Thakur H; Cozacov Z; Rusconi F; Wieczorek D; Sanders M; Li J; Kapiloff MS
    Am J Physiol Heart Circ Physiol; 2013 Oct; 305(7):H1010-9. PubMed ID: 23913705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RSK3 is required for concentric myocyte hypertrophy in an activated Raf1 model for Noonan syndrome.
    Passariello CL; Martinez EC; Thakur H; Cesareo M; Li J; Kapiloff MS
    J Mol Cell Cardiol; 2016 Apr; 93():98-105. PubMed ID: 26940993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
    Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
    Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin Aβ-Specific Anchoring Confers Isoform-Specific Compartmentation and Function in Pathological Cardiac Myocyte Hypertrophy.
    Li X; Li J; Martinez EC; Froese A; Passariello CL; Henshaw K; Rusconi F; Li Y; Yu Q; Thakur H; Nikolaev VO; Kapiloff MS
    Circulation; 2020 Sep; 142(10):948-962. PubMed ID: 32611257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
    Roux PP; Richards SA; Blenis J
    Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Hypertrophy Is Inhibited by a Local Pool of cAMP Regulated by Phosphodiesterase 2.
    Zoccarato A; Surdo NC; Aronsen JM; Fields LA; Mancuso L; Dodoni G; Stangherlin A; Livie C; Jiang H; Sin YY; Gesellchen F; Terrin A; Baillie GS; Nicklin SA; Graham D; Szabo-Fresnais N; Krall J; Vandeput F; Movsesian M; Furlan L; Corsetti V; Hamilton G; Lefkimmiatis K; Sjaastad I; Zaccolo M
    Circ Res; 2015 Sep; 117(8):707-19. PubMed ID: 26243800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empagliflozin mitigates cardiac hypertrophy through cardiac RSK/NHE-1 inhibition.
    Chen S; Overberg K; Ghouse Z; Hollmann MW; Weber NC; Coronel R; Zuurbier CJ
    Biomed Pharmacother; 2024 May; 174():116477. PubMed ID: 38522235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-Converting Enzyme 3 (ACE3) Protects Against Pressure Overload-Induced Cardiac Hypertrophy.
    Yu CJ; Tang LL; Liang C; Chen X; Song SY; Ding XQ; Zhang KY; Song BL; Zhao D; Zhu XY; Li HL; Zhang ZR
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26892527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart.
    Kimura TE; Jin J; Zi M; Prehar S; Liu W; Oceandy D; Abe J; Neyses L; Weston AH; Cartwright EJ; Wang X
    Circ Res; 2010 Mar; 106(5):961-70. PubMed ID: 20075332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMP type I receptor ALK2 is required for angiotensin II-induced cardiac hypertrophy.
    Shahid M; Spagnolli E; Ernande L; Thoonen R; Kolodziej SA; Leyton PA; Cheng J; Tainsh RE; Mayeur C; Rhee DK; Wu MX; Scherrer-Crosbie M; Buys ES; Zapol WM; Bloch KD; Bloch DB
    Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H984-94. PubMed ID: 26873969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT.
    Matsuda T; Jeong JI; Ikeda S; Yamamoto T; Gao S; Babu GJ; Zhai P; Del Re DP
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28193718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RSK3 mediates necroptosis by regulating phosphorylation of RIP3 in rat retinal ganglion cells.
    Wang M; Wan H; Wang S; Liao L; Huang Y; Guo L; Liu F; Shang L; Huang J; Ji D; Xia X; Jiang B; Chen D; Xiong K
    J Anat; 2020 Jul; 237(1):29-47. PubMed ID: 32162697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases.
    Zhao Y; Bjorbaek C; Moller DE
    J Biol Chem; 1996 Nov; 271(47):29773-9. PubMed ID: 8939914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy.
    Pérez López I; Cariolato L; Maric D; Gillet L; Abriel H; Diviani D
    Mol Cell Biol; 2013 Aug; 33(15):2903-17. PubMed ID: 23716597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload.
    Schnelle M; Sawyer I; Anilkumar N; Mohamed BA; Richards DA; Toischer K; Zhang M; Catibog N; Sawyer G; Mongue-Din H; Schröder K; Hasenfuss G; Shah AM
    Cardiovasc Res; 2021 Jan; 117(1):178-187. PubMed ID: 31821410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
    Li L; Li J; Drum BM; Chen Y; Yin H; Guo X; Luckey SW; Gilbert ML; McKnight GS; Scott JD; Santana LF; Liu Q
    Cardiovasc Res; 2017 Feb; 113(2):147-159. PubMed ID: 27856611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.